Aftab Dana 4
4 · EXELIXIS, INC. · Filed Nov 13, 2025
Insider Transaction Report
Form 4
EXELIXIS, INC.EXEL
Aftab Dana
EVP, Research and Development
Transactions
- Sale
Common Stock
2025-11-11$42.50/sh−48,383$2,056,278→ 664,778 total
Holdings
- 5,835(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.50 to $42.58. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.
- [F2]Includes 431,306 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSU"). Each RSU is the economic equivalent of one share of Common Stock.
- [F3]Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of November 10, 2025.